

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.35281328 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 4.55255706 |
| 3 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.42294924 |
| 4 | DNA strand elongation (GO:0022616) | 4.27718366 |
| 5 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.18649267 |
| 6 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.07409357 |
| 7 | NADH metabolic process (GO:0006734) | 4.00415451 |
| 8 | proline biosynthetic process (GO:0006561) | 3.97685079 |
| 9 | DNA replication initiation (GO:0006270) | 3.91248598 |
| 10 | DNA unwinding involved in DNA replication (GO:0006268) | 3.85307062 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 3.82932563 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 3.82932563 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 3.79623636 |
| 14 | glycine metabolic process (GO:0006544) | 3.77808370 |
| 15 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.76208574 |
| 16 | negative regulation of cell size (GO:0045792) | 3.72711230 |
| 17 | viral transcription (GO:0019083) | 3.67866645 |
| 18 | nucleobase biosynthetic process (GO:0046112) | 3.67068927 |
| 19 | pentose-phosphate shunt (GO:0006098) | 3.64330929 |
| 20 | translational termination (GO:0006415) | 3.61050423 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60025401 |
| 22 | telomere maintenance via recombination (GO:0000722) | 3.58692826 |
| 23 | serine family amino acid biosynthetic process (GO:0009070) | 3.51747633 |
| 24 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.51602115 |
| 25 | pinocytosis (GO:0006907) | 3.49179750 |
| 26 | protein maturation by protein folding (GO:0022417) | 3.48310105 |
| 27 | purine nucleobase biosynthetic process (GO:0009113) | 3.47057633 |
| 28 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.41747719 |
| 29 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.37215829 |
| 30 | * translational elongation (GO:0006414) | 3.37161123 |
| 31 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.34992055 |
| 32 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.32276324 |
| 33 | mitotic recombination (GO:0006312) | 3.30389667 |
| 34 | formation of translation preinitiation complex (GO:0001731) | 3.29398514 |
| 35 | tetrahydrofolate metabolic process (GO:0046653) | 3.28995741 |
| 36 | folic acid metabolic process (GO:0046655) | 3.27651263 |
| 37 | L-serine metabolic process (GO:0006563) | 3.27341839 |
| 38 | GDP-mannose metabolic process (GO:0019673) | 3.27155234 |
| 39 | telomere maintenance via telomere lengthening (GO:0010833) | 3.24242243 |
| 40 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.22028471 |
| 41 | histone arginine methylation (GO:0034969) | 3.20565958 |
| 42 | proteasome assembly (GO:0043248) | 3.20334698 |
| 43 | pentose metabolic process (GO:0019321) | 3.18541716 |
| 44 | NADPH regeneration (GO:0006740) | 3.16949737 |
| 45 | DNA replication checkpoint (GO:0000076) | 3.16139611 |
| 46 | glucose catabolic process (GO:0006007) | 3.14790690 |
| 47 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.13262653 |
| 48 | ribosomal large subunit biogenesis (GO:0042273) | 3.12693705 |
| 49 | cotranslational protein targeting to membrane (GO:0006613) | 3.11346816 |
| 50 | IMP biosynthetic process (GO:0006188) | 3.11048479 |
| 51 | protein targeting to ER (GO:0045047) | 3.09636380 |
| 52 | L-phenylalanine metabolic process (GO:0006558) | 3.05848916 |
| 53 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.05848916 |
| 54 | tricarboxylic acid metabolic process (GO:0072350) | 3.04672745 |
| 55 | pseudouridine synthesis (GO:0001522) | 3.04462526 |
| 56 | ribosomal small subunit biogenesis (GO:0042274) | 3.03070885 |
| 57 | translational initiation (GO:0006413) | 3.02907832 |
| 58 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.01327851 |
| 59 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.99757840 |
| 60 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.98139838 |
| 61 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.98139838 |
| 62 | protein localization to endoplasmic reticulum (GO:0070972) | 2.96727091 |
| 63 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.94931906 |
| 64 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.93535653 |
| 65 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.93338259 |
| 66 | oxaloacetate metabolic process (GO:0006107) | 2.91457959 |
| 67 | ribosome biogenesis (GO:0042254) | 2.91247562 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 2.91185810 |
| 69 | CENP-A containing nucleosome assembly (GO:0034080) | 2.90825239 |
| 70 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.90008992 |
| 71 | proline metabolic process (GO:0006560) | 2.89906870 |
| 72 | chromatin remodeling at centromere (GO:0031055) | 2.89835148 |
| 73 | cellular response to interleukin-4 (GO:0071353) | 2.89456859 |
| 74 | one-carbon metabolic process (GO:0006730) | 2.88170321 |
| 75 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88042759 |
| 76 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88042759 |
| 77 | mitotic nuclear envelope disassembly (GO:0007077) | 2.87763972 |
| 78 | pyrimidine-containing compound salvage (GO:0008655) | 2.86967104 |
| 79 | pyrimidine nucleoside salvage (GO:0043097) | 2.86967104 |
| 80 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.86414268 |
| 81 | L-phenylalanine catabolic process (GO:0006559) | 2.86414268 |
| 82 | protein retention in ER lumen (GO:0006621) | 2.84827743 |
| 83 | peptidyl-arginine methylation (GO:0018216) | 2.84212815 |
| 84 | peptidyl-arginine N-methylation (GO:0035246) | 2.84212815 |
| 85 | folic acid-containing compound metabolic process (GO:0006760) | 2.83194912 |
| 86 | nucleotide salvage (GO:0043173) | 2.82461189 |
| 87 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.82213079 |
| 88 | viral life cycle (GO:0019058) | 2.81052466 |
| 89 | spliceosomal snRNP assembly (GO:0000387) | 2.80147233 |
| 90 | UV protection (GO:0009650) | 2.78653412 |
| 91 | negative regulation of B cell apoptotic process (GO:0002903) | 2.77873024 |
| 92 | cellular hyperosmotic response (GO:0071474) | 2.77122553 |
| 93 | cellular protein complex disassembly (GO:0043624) | 2.76947653 |
| 94 | IMP metabolic process (GO:0046040) | 2.76788869 |
| 95 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.76470450 |
| 96 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.75965967 |
| 97 | modulation by virus of host process (GO:0019054) | 2.75300173 |
| 98 | apoptotic process involved in morphogenesis (GO:0060561) | 2.73178670 |
| 99 | regulation of mitochondrial translation (GO:0070129) | 2.72215080 |
| 100 | protein localization to kinetochore (GO:0034501) | 2.71977532 |
| 101 | regulation of superoxide anion generation (GO:0032928) | 2.70708570 |
| 102 | nucleoside salvage (GO:0043174) | 2.69002928 |
| 103 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.68369215 |
| 104 | DNA duplex unwinding (GO:0032508) | 2.68191076 |
| 105 | rRNA processing (GO:0006364) | 2.67806282 |
| 106 | urea cycle (GO:0000050) | 2.67448309 |
| 107 | pteridine-containing compound metabolic process (GO:0042558) | 2.67308079 |
| 108 | DNA geometric change (GO:0032392) | 2.66987547 |
| 109 | regulation of translational fidelity (GO:0006450) | 2.66619262 |
| 110 | glucose 6-phosphate metabolic process (GO:0051156) | 2.66435600 |
| 111 | telomere organization (GO:0032200) | 2.66319073 |
| 112 | telomere maintenance (GO:0000723) | 2.65736344 |
| 113 | monosaccharide biosynthetic process (GO:0046364) | 2.64644465 |
| 114 | neutrophil activation involved in immune response (GO:0002283) | 2.64479127 |
| 115 | mitochondrial fusion (GO:0008053) | 2.61189998 |
| 116 | rRNA metabolic process (GO:0016072) | 2.60313355 |
| 117 | nuclear envelope disassembly (GO:0051081) | 2.59980787 |
| 118 | membrane disassembly (GO:0030397) | 2.59980787 |
| 119 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59727242 |
| 120 | translation (GO:0006412) | 2.59549845 |
| 121 | negative regulation of necroptotic process (GO:0060546) | 2.59322379 |
| 122 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.58805333 |
| 123 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.58386774 |
| 124 | UMP metabolic process (GO:0046049) | 2.58386774 |
| 125 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.58386774 |
| 126 | UMP biosynthetic process (GO:0006222) | 2.58386774 |
| 127 | protein localization to chromosome, centromeric region (GO:0071459) | 2.58090308 |
| 128 | aromatic amino acid family catabolic process (GO:0009074) | 2.56779046 |
| 129 | positive thymic T cell selection (GO:0045059) | 2.56601901 |
| 130 | response to peptidoglycan (GO:0032494) | 2.56081245 |
| 131 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.55054854 |
| 132 | DNA replication-independent nucleosome organization (GO:0034724) | 2.55054854 |
| 133 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.55041231 |
| 134 | glyoxylate metabolic process (GO:0046487) | 2.54423181 |
| 135 | protein complex disassembly (GO:0043241) | 2.54307447 |
| 136 | snRNA metabolic process (GO:0016073) | 2.54011783 |
| 137 | ribosome assembly (GO:0042255) | 2.53688819 |
| 138 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.52511518 |
| 139 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.52511518 |
| 140 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.52216686 |
| 141 | iron-sulfur cluster assembly (GO:0016226) | 2.52041817 |
| 142 | metallo-sulfur cluster assembly (GO:0031163) | 2.52041817 |
| 143 | serine family amino acid catabolic process (GO:0009071) | 2.51336362 |
| 144 | metaphase plate congression (GO:0051310) | 2.50167090 |
| 145 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.50150905 |
| 146 | mismatch repair (GO:0006298) | 2.49988417 |
| 147 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.49421608 |
| 148 | 2-oxoglutarate metabolic process (GO:0006103) | 2.49361511 |
| 149 | urea metabolic process (GO:0019627) | 2.48426867 |
| 150 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.48386212 |
| 151 | nitrogen cycle metabolic process (GO:0071941) | 2.47483854 |
| 152 | modulation by symbiont of host defense response (GO:0052031) | 2.47121123 |
| 153 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.47121123 |
| 154 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.47121123 |
| 155 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.47121123 |
| 156 | modulation by symbiont of host immune response (GO:0052553) | 2.47121123 |
| 157 | positive regulation by symbiont of host defense response (GO:0052509) | 2.47121123 |
| 158 | gluconeogenesis (GO:0006094) | 2.45766931 |
| 159 | response to interleukin-4 (GO:0070670) | 2.45486175 |
| 160 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.45379369 |
| 161 | amino acid salvage (GO:0043102) | 2.44767681 |
| 162 | L-methionine salvage (GO:0071267) | 2.44767681 |
| 163 | L-methionine biosynthetic process (GO:0071265) | 2.44767681 |
| 164 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.44749047 |
| 165 | establishment of integrated proviral latency (GO:0075713) | 2.44263506 |
| 166 | NIK/NF-kappaB signaling (GO:0038061) | 2.44070688 |
| 167 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.43974611 |
| 168 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.43375709 |
| 169 | modulation by symbiont of host cellular process (GO:0044068) | 2.42197290 |
| 170 | regulation of defense response to virus by virus (GO:0050690) | 2.42100570 |
| 171 | macromolecular complex disassembly (GO:0032984) | 2.41052976 |
| 172 | histone exchange (GO:0043486) | 2.40610632 |
| 173 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.40559386 |
| 174 | virion assembly (GO:0019068) | 2.39620616 |
| 175 | regulation of monocyte differentiation (GO:0045655) | 2.37670283 |
| 176 | response to muramyl dipeptide (GO:0032495) | 2.37281012 |
| 177 | hexose biosynthetic process (GO:0019319) | 2.36392308 |
| 178 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.36381528 |
| 179 | protein insertion into membrane (GO:0051205) | 2.35789992 |
| 180 | protein-DNA complex disassembly (GO:0032986) | 2.35534366 |
| 181 | nucleosome disassembly (GO:0006337) | 2.35534366 |
| 182 | thymic T cell selection (GO:0045061) | 2.33834018 |
| 183 | activation of MAPKKK activity (GO:0000185) | 2.33766955 |
| 184 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.32571555 |
| 185 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.30148199 |
| 186 | dosage compensation (GO:0007549) | 2.28730998 |
| 187 | tricarboxylic acid cycle (GO:0006099) | 2.28109311 |
| 188 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.27714043 |
| 189 | ncRNA 3-end processing (GO:0043628) | 2.25766489 |
| 190 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.24542384 |
| 191 | rRNA transcription (GO:0009303) | 2.24520113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.08799869 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89441236 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.83336485 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82396687 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79373394 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.73286920 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.71512901 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.70032764 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66534835 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.60050046 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52890879 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.52478695 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.47256869 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45258800 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.45034250 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43829353 |
| 17 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.38315327 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32651882 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.29022637 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27514444 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.17353067 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.16435140 |
| 23 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15533932 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.13480451 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.06026130 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.04948060 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04342316 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95504396 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94336511 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.91687541 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.91053534 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.90586509 |
| 33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90569112 |
| 34 | MYC_22102868_ChIP-Seq_BL_Human | 1.89396664 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89243765 |
| 36 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.83223008 |
| 37 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82382083 |
| 38 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80536500 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76139561 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75223356 |
| 41 | * AR_21909140_ChIP-Seq_LNCAP_Human | 1.73486099 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69741534 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66201418 |
| 44 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.64459081 |
| 45 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64450379 |
| 46 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.63629026 |
| 47 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.63386850 |
| 48 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.61602312 |
| 49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.61276040 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.59273717 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.56147746 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55036128 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.54669372 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54652745 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 1.54565963 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54441697 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54027291 |
| 58 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.53992493 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.53540828 |
| 60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52694255 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50011925 |
| 62 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48414485 |
| 63 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47640421 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.46829368 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46698158 |
| 66 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46620813 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46254323 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45867762 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.45305289 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.43007778 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.41722094 |
| 72 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.40474096 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40278534 |
| 74 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.39181314 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.36520149 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35370583 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.34893033 |
| 78 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34848385 |
| 79 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.33519719 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33215329 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30992381 |
| 82 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30128178 |
| 83 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.29506027 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28877407 |
| 85 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27812279 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26417544 |
| 87 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26389301 |
| 88 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26288770 |
| 89 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26176242 |
| 90 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.25997182 |
| 91 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25803257 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25149704 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.24112749 |
| 94 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.24072642 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.23754867 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23601096 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.22431207 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22265726 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21782453 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20653102 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20255704 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18673119 |
| 103 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18217545 |
| 104 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.16645195 |
| 105 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16041310 |
| 106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15966911 |
| 107 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.14820163 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14784130 |
| 109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14678675 |
| 110 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13850513 |
| 111 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12586735 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.12404628 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11305641 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.11236678 |
| 115 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11050921 |
| 116 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09033601 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08532114 |
| 118 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.08456126 |
| 119 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08248101 |
| 120 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06283313 |
| 121 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06109906 |
| 122 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.04705890 |
| 123 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04580413 |
| 124 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.03689968 |
| 125 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.02784734 |
| 126 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.00492525 |
| 127 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.00453538 |
| 128 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99374826 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98748030 |
| 130 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98691628 |
| 131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.97827765 |
| 132 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97397198 |
| 133 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.96989944 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.95221150 |
| 135 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.95199864 |
| 136 | UTX_26944678_Chip-Seq_JUKART_Human | 0.93389691 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91283447 |
| 138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.89005746 |
| 139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87791060 |
| 140 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87217473 |
| 141 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86655018 |
| 142 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86229085 |
| 143 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85074892 |
| 144 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84609070 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.84046480 |
| 146 | MYB_26560356_Chip-Seq_TH1_Human | 0.82391405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.92169428 |
| 2 | MP0005451_abnormal_body_composition | 3.83619748 |
| 3 | MP0005360_urolithiasis | 3.79681402 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.75129022 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.43247660 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.29976977 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.25711212 |
| 8 | MP0008260_abnormal_autophagy | 3.07674264 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.04866850 |
| 10 | MP0005365_abnormal_bile_salt | 2.98973616 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.95624071 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.91681454 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.67252838 |
| 14 | MP0003077_abnormal_cell_cycle | 2.66129860 |
| 15 | MP0004233_abnormal_muscle_weight | 2.59376270 |
| 16 | MP0008058_abnormal_DNA_repair | 2.55956942 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37565815 |
| 18 | MP0008007_abnormal_cellular_replicative | 2.11038279 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.10921928 |
| 20 | MP0008057_abnormal_DNA_replication | 2.03738336 |
| 21 | MP0004858_abnormal_nervous_system | 1.99857139 |
| 22 | MP0009278_abnormal_bone_marrow | 1.91893696 |
| 23 | MP0000685_abnormal_immune_system | 1.88746128 |
| 24 | MP0009840_abnormal_foam_cell | 1.87102130 |
| 25 | MP0005075_abnormal_melanosome_morpholog | 1.84855822 |
| 26 | MP0000490_abnormal_crypts_of | 1.72617208 |
| 27 | MP0003303_peritoneal_inflammation | 1.70731153 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.67078897 |
| 29 | MP0003195_calcinosis | 1.66286687 |
| 30 | MP0003186_abnormal_redox_activity | 1.65451033 |
| 31 | MP0000858_altered_metastatic_potential | 1.63112705 |
| 32 | MP0001764_abnormal_homeostasis | 1.57650944 |
| 33 | MP0005670_abnormal_white_adipose | 1.56999335 |
| 34 | MP0000751_myopathy | 1.53948678 |
| 35 | MP0001730_embryonic_growth_arrest | 1.52759256 |
| 36 | MP0003252_abnormal_bile_duct | 1.52583105 |
| 37 | MP0005671_abnormal_response_to | 1.52377325 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.49286638 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.48087409 |
| 40 | MP0002419_abnormal_innate_immunity | 1.46526920 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.44979629 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.44254810 |
| 43 | MP0004808_abnormal_hematopoietic_stem | 1.43721492 |
| 44 | MP0008932_abnormal_embryonic_tissue | 1.42729017 |
| 45 | MP0000689_abnormal_spleen_morphology | 1.41723530 |
| 46 | MP0002019_abnormal_tumor_incidence | 1.41470251 |
| 47 | MP0002722_abnormal_immune_system | 1.41172974 |
| 48 | MP0002398_abnormal_bone_marrow | 1.41125268 |
| 49 | MP0003786_premature_aging | 1.41054174 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.38340001 |
| 51 | MP0002132_abnormal_respiratory_system | 1.37851135 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.37747685 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.37302273 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.37302273 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.37269195 |
| 56 | MP0003075_altered_response_to | 1.36282749 |
| 57 | MP0005332_abnormal_amino_acid | 1.35084467 |
| 58 | MP0000678_abnormal_parathyroid_gland | 1.34529214 |
| 59 | MP0010352_gastrointestinal_tract_polyps | 1.33362407 |
| 60 | MP0005666_abnormal_adipose_tissue | 1.32627009 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.30022417 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.30013749 |
| 63 | MP0000609_abnormal_liver_physiology | 1.27690716 |
| 64 | MP0000747_muscle_weakness | 1.27175046 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.25728500 |
| 66 | MP0003718_maternal_effect | 1.23813321 |
| 67 | MP0001835_abnormal_antigen_presentation | 1.23328613 |
| 68 | MP0005387_immune_system_phenotype | 1.22849271 |
| 69 | MP0001790_abnormal_immune_system | 1.22849271 |
| 70 | MP0000350_abnormal_cell_proliferation | 1.21964634 |
| 71 | MP0000598_abnormal_liver_morphology | 1.21707446 |
| 72 | MP0000313_abnormal_cell_death | 1.20838262 |
| 73 | MP0005083_abnormal_biliary_tract | 1.20689756 |
| 74 | MP0005330_cardiomyopathy | 1.20247421 |
| 75 | MP0003436_decreased_susceptibility_to | 1.19170679 |
| 76 | MP0001800_abnormal_humoral_immune | 1.18967565 |
| 77 | MP0002429_abnormal_blood_cell | 1.17706632 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.17161651 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.17129943 |
| 80 | MP0001666_abnormal_nutrient_absorption | 1.16451275 |
| 81 | MP0009697_abnormal_copulation | 1.15713837 |
| 82 | MP0005501_abnormal_skin_physiology | 1.15186674 |
| 83 | MP0002249_abnormal_larynx_morphology | 1.13826452 |
| 84 | MP0001873_stomach_inflammation | 1.13561869 |
| 85 | MP0003300_gastrointestinal_ulcer | 1.11404718 |
| 86 | MP0004947_skin_inflammation | 1.10172388 |
| 87 | MP0000716_abnormal_immune_system | 1.09794685 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 1.08830707 |
| 89 | MP0001853_heart_inflammation | 1.08586090 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 1.07541009 |
| 91 | MP0000681_abnormal_thyroid_gland | 1.06806136 |
| 92 | MP0006054_spinal_hemorrhage | 1.06327960 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 1.03585565 |
| 94 | MP0002080_prenatal_lethality | 1.03399648 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.02796642 |
| 96 | MP0000759_abnormal_skeletal_muscle | 1.02473729 |
| 97 | MP0003566_abnormal_cell_adhesion | 1.02226676 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.98747703 |
| 99 | MP0001849_ear_inflammation | 0.98409538 |
| 100 | MP0001697_abnormal_embryo_size | 0.97929359 |
| 101 | MP0005375_adipose_tissue_phenotype | 0.97536605 |
| 102 | MP0008877_abnormal_DNA_methylation | 0.95732304 |
| 103 | MP0002420_abnormal_adaptive_immunity | 0.95052073 |
| 104 | MP0009785_altered_susceptibility_to | 0.94171730 |
| 105 | MP0008469_abnormal_protein_level | 0.93393677 |
| 106 | MP0001819_abnormal_immune_cell | 0.93161338 |
| 107 | MP0009763_increased_sensitivity_to | 0.92975772 |
| 108 | MP0000358_abnormal_cell_content/ | 0.92889202 |
| 109 | MP0005025_abnormal_response_to | 0.92543223 |
| 110 | MP0002723_abnormal_immune_serum | 0.91695314 |
| 111 | MP0002452_abnormal_antigen_presenting | 0.90328945 |
| 112 | MP0002405_respiratory_system_inflammati | 0.90268513 |
| 113 | MP0001929_abnormal_gametogenesis | 0.89510733 |
| 114 | MP0002796_impaired_skin_barrier | 0.89264158 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.88507585 |
| 116 | MP0001533_abnormal_skeleton_physiology | 0.88276653 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.87392950 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.86406089 |
| 119 | MP0002269_muscular_atrophy | 0.85788614 |
| 120 | MP0003868_abnormal_feces_composition | 0.85262533 |
| 121 | MP0010307_abnormal_tumor_latency | 0.85030444 |
| 122 | MP0003866_abnormal_defecation | 0.85008665 |
| 123 | MP0003646_muscle_fatigue | 0.84075461 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.81277716 |
| 125 | MP0000604_amyloidosis | 0.81077285 |
| 126 | MP0002970_abnormal_white_adipose | 0.80916917 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.80786881 |
| 128 | MP0004147_increased_porphyrin_level | 0.80634287 |
| 129 | MP0002210_abnormal_sex_determination | 0.80188676 |
| 130 | MP0000372_irregular_coat_pigmentation | 0.80031308 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.79160008 |
| 132 | MP0005380_embryogenesis_phenotype | 0.78050737 |
| 133 | MP0001672_abnormal_embryogenesis/_devel | 0.78050737 |
| 134 | MP0002009_preneoplasia | 0.77959801 |
| 135 | MP0005408_hypopigmentation | 0.77876564 |
| 136 | MP0005621_abnormal_cell_physiology | 0.77161160 |
| 137 | MP0005023_abnormal_wound_healing | 0.77110235 |
| 138 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77030767 |
| 139 | MP0002086_abnormal_extraembryonic_tissu | 0.76554116 |
| 140 | MP0001145_abnormal_male_reproductive | 0.76441752 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.76230943 |
| 142 | MP0000477_abnormal_intestine_morphology | 0.76057123 |
| 143 | MP0002095_abnormal_skin_pigmentation | 0.74940918 |
| 144 | MP0005174_abnormal_tail_pigmentation | 0.74136461 |
| 145 | MP0004019_abnormal_vitamin_homeostasis | 0.73641692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.10469588 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.10172027 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.06301348 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.00085918 |
| 5 | Oral leukoplakia (HP:0002745) | 3.84348779 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.79146094 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.64853603 |
| 8 | Aplastic anemia (HP:0001915) | 3.62662683 |
| 9 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.59590457 |
| 10 | Ragged-red muscle fibers (HP:0003200) | 3.51454722 |
| 11 | Abnormal gallbladder physiology (HP:0012438) | 3.40337828 |
| 12 | Cholecystitis (HP:0001082) | 3.40337828 |
| 13 | Reticulocytopenia (HP:0001896) | 3.25895894 |
| 14 | Intrahepatic cholestasis (HP:0001406) | 3.23329495 |
| 15 | Colon cancer (HP:0003003) | 3.13181979 |
| 16 | Microvesicular hepatic steatosis (HP:0001414) | 3.04309658 |
| 17 | Hypoplasia of the thymus (HP:0000778) | 3.01060343 |
| 18 | Deep venous thrombosis (HP:0002625) | 2.98321802 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.95329639 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.95329639 |
| 21 | Fatigue (HP:0012378) | 2.90879610 |
| 22 | Birth length less than 3rd percentile (HP:0003561) | 2.81767027 |
| 23 | Exercise-induced myalgia (HP:0003738) | 2.79128879 |
| 24 | Thrombocytosis (HP:0001894) | 2.75343325 |
| 25 | IgM deficiency (HP:0002850) | 2.74543723 |
| 26 | Hypertensive crisis (HP:0100735) | 2.74178823 |
| 27 | Vertebral compression fractures (HP:0002953) | 2.71660666 |
| 28 | Agnosia (HP:0010524) | 2.65322490 |
| 29 | Macrocytic anemia (HP:0001972) | 2.64900722 |
| 30 | Rhabdomyolysis (HP:0003201) | 2.63375504 |
| 31 | Ependymoma (HP:0002888) | 2.63347787 |
| 32 | Hyperammonemia (HP:0001987) | 2.63206231 |
| 33 | Prolonged partial thromboplastin time (HP:0003645) | 2.63093494 |
| 34 | Petechiae (HP:0000967) | 2.60781585 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.59774342 |
| 36 | Long palpebral fissure (HP:0000637) | 2.58418375 |
| 37 | Rhabdomyosarcoma (HP:0002859) | 2.57349127 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.56104472 |
| 39 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.53443887 |
| 40 | Achilles tendon contracture (HP:0001771) | 2.51558516 |
| 41 | Cellulitis (HP:0100658) | 2.50781812 |
| 42 | Abnormality of the Achilles tendon (HP:0005109) | 2.50259222 |
| 43 | Pallor (HP:0000980) | 2.49872698 |
| 44 | Cholelithiasis (HP:0001081) | 2.49508115 |
| 45 | Abnormality of methionine metabolism (HP:0010901) | 2.49046439 |
| 46 | Microretrognathia (HP:0000308) | 2.49032046 |
| 47 | Increased connective tissue (HP:0009025) | 2.47915452 |
| 48 | Myopathic facies (HP:0002058) | 2.45395424 |
| 49 | Progressive muscle weakness (HP:0003323) | 2.43929037 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.39790855 |
| 51 | Thoracic kyphosis (HP:0002942) | 2.39038478 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.38131262 |
| 53 | Xanthomatosis (HP:0000991) | 2.37589937 |
| 54 | Seborrheic dermatitis (HP:0001051) | 2.34437854 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.34248962 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34210778 |
| 57 | Obstructive lung disease (HP:0006536) | 2.34210778 |
| 58 | Nausea (HP:0002018) | 2.33399192 |
| 59 | Distal lower limb amyotrophy (HP:0008944) | 2.32258812 |
| 60 | Gonadotropin excess (HP:0000837) | 2.32156802 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.31458950 |
| 62 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.28459149 |
| 63 | Reticulocytosis (HP:0001923) | 2.27553529 |
| 64 | Medulloblastoma (HP:0002885) | 2.27031597 |
| 65 | Dysostosis multiplex (HP:0000943) | 2.24977686 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.24017970 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.22906046 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.22769864 |
| 69 | Basal cell carcinoma (HP:0002671) | 2.21943270 |
| 70 | Abnormality of the thoracic spine (HP:0100711) | 2.20884345 |
| 71 | Pancytopenia (HP:0001876) | 2.20233191 |
| 72 | Abnormality of serum amino acid levels (HP:0003112) | 2.20174654 |
| 73 | Increased serum lactate (HP:0002151) | 2.19230644 |
| 74 | Premature graying of hair (HP:0002216) | 2.18584328 |
| 75 | Acute hepatic failure (HP:0006554) | 2.17927838 |
| 76 | Secondary amenorrhea (HP:0000869) | 2.17459185 |
| 77 | Colitis (HP:0002583) | 2.15462241 |
| 78 | Amaurosis fugax (HP:0100576) | 2.15227645 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.14789492 |
| 80 | Trismus (HP:0000211) | 2.12891797 |
| 81 | Systemic lupus erythematosus (HP:0002725) | 2.11205567 |
| 82 | Spastic diplegia (HP:0001264) | 2.10666651 |
| 83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.09653487 |
| 84 | Recurrent bronchitis (HP:0002837) | 2.09152911 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08789839 |
| 86 | Hyperacusis (HP:0010780) | 2.08060127 |
| 87 | Reduced antithrombin III activity (HP:0001976) | 2.05577126 |
| 88 | Rough bone trabeculation (HP:0100670) | 2.05048076 |
| 89 | Lymphoma (HP:0002665) | 2.04502565 |
| 90 | Hepatic necrosis (HP:0002605) | 2.04365971 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.03713627 |
| 92 | Abnormality of alanine metabolism (HP:0010916) | 2.03713627 |
| 93 | Hyperalaninemia (HP:0003348) | 2.03713627 |
| 94 | Muscle fiber atrophy (HP:0100295) | 2.03136455 |
| 95 | Poikiloderma (HP:0001029) | 2.02540161 |
| 96 | Abnormality of reticulocytes (HP:0004312) | 2.02102212 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 2.01642895 |
| 98 | Cellular immunodeficiency (HP:0005374) | 2.01012096 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.00029616 |
| 100 | Increased muscle lipid content (HP:0009058) | 1.99450987 |
| 101 | Abnormality of macrophages (HP:0004311) | 1.98639577 |
| 102 | Recurrent abscess formation (HP:0002722) | 1.96968875 |
| 103 | Hyperlipoproteinemia (HP:0010980) | 1.96536970 |
| 104 | Dicarboxylic aciduria (HP:0003215) | 1.96180461 |
| 105 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96180461 |
| 106 | Ketosis (HP:0001946) | 1.95950925 |
| 107 | Agammaglobulinemia (HP:0004432) | 1.95222282 |
| 108 | Hyperglycinemia (HP:0002154) | 1.94866544 |
| 109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.94855257 |
| 110 | Epistaxis (HP:0000421) | 1.94796204 |
| 111 | Mediastinal lymphadenopathy (HP:0100721) | 1.94692424 |
| 112 | Combined immunodeficiency (HP:0005387) | 1.94515681 |
| 113 | Prolonged bleeding time (HP:0003010) | 1.93810226 |
| 114 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93792995 |
| 115 | Hepatosplenomegaly (HP:0001433) | 1.93573636 |
| 116 | Neoplasm of the pancreas (HP:0002894) | 1.93458306 |
| 117 | Abnormality of nucleobase metabolism (HP:0010932) | 1.92913027 |
| 118 | Abnormality of the gallbladder (HP:0005264) | 1.92606948 |
| 119 | Degeneration of anterior horn cells (HP:0002398) | 1.92067542 |
| 120 | Abnormality of the anterior horn cell (HP:0006802) | 1.92067542 |
| 121 | Type 2 muscle fiber atrophy (HP:0003554) | 1.91653044 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.91557190 |
| 123 | Growth hormone excess (HP:0000845) | 1.91337032 |
| 124 | Myelodysplasia (HP:0002863) | 1.90563784 |
| 125 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90057200 |
| 126 | Increased IgE level (HP:0003212) | 1.88876690 |
| 127 | Abnormal platelet volume (HP:0011876) | 1.88705981 |
| 128 | Myoglobinuria (HP:0002913) | 1.88538281 |
| 129 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88243391 |
| 130 | Increased variability in muscle fiber diameter (HP:0003557) | 1.88095867 |
| 131 | Panhypogammaglobulinemia (HP:0003139) | 1.86999377 |
| 132 | Cerebral palsy (HP:0100021) | 1.86581064 |
| 133 | 11 pairs of ribs (HP:0000878) | 1.86250835 |
| 134 | Asymmetric septal hypertrophy (HP:0001670) | 1.85965602 |
| 135 | Recurrent viral infections (HP:0004429) | 1.85907063 |
| 136 | Abnormality of B cell number (HP:0010975) | 1.84805862 |
| 137 | B lymphocytopenia (HP:0010976) | 1.84805862 |
| 138 | Breast hypoplasia (HP:0003187) | 1.84805030 |
| 139 | Increased serum ferritin (HP:0003281) | 1.84715393 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84536458 |
| 141 | Megaloblastic anemia (HP:0001889) | 1.84034781 |
| 142 | Brushfield spots (HP:0001088) | 1.83949861 |
| 143 | Acanthocytosis (HP:0001927) | 1.83672170 |
| 144 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83585415 |
| 145 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83585415 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83585415 |
| 147 | Diaphragmatic weakness (HP:0009113) | 1.83403903 |
| 148 | Easy fatigability (HP:0003388) | 1.83253306 |
| 149 | Premature ovarian failure (HP:0008209) | 1.82112777 |
| 150 | Abnormality of T cells (HP:0002843) | 1.81870807 |
| 151 | Purpura (HP:0000979) | 1.81855464 |
| 152 | Poikilocytosis (HP:0004447) | 1.80951568 |
| 153 | Impaired platelet aggregation (HP:0003540) | 1.80697805 |
| 154 | Abnormal platelet function (HP:0011869) | 1.80697805 |
| 155 | Joint hemorrhage (HP:0005261) | 1.80493767 |
| 156 | Microcytic anemia (HP:0001935) | 1.80448144 |
| 157 | Broad distal phalanx of finger (HP:0009836) | 1.80376524 |
| 158 | Abnormality of glycolysis (HP:0004366) | 1.79946167 |
| 159 | Polygenic inheritance (HP:0010982) | 1.79527065 |
| 160 | Polycythemia (HP:0001901) | 1.79467538 |
| 161 | Hypoglycemic coma (HP:0001325) | 1.78824433 |
| 162 | Abnormal spermatogenesis (HP:0008669) | 1.78436348 |
| 163 | Late onset (HP:0003584) | 1.77901275 |
| 164 | Hepatocellular necrosis (HP:0001404) | 1.77724880 |
| 165 | Gastrointestinal stroma tumor (HP:0100723) | 1.77074931 |
| 166 | Inflammation of the large intestine (HP:0002037) | 1.77005734 |
| 167 | Multiple enchondromatosis (HP:0005701) | 1.76632803 |
| 168 | Progressive external ophthalmoplegia (HP:0000590) | 1.75199718 |
| 169 | Testicular atrophy (HP:0000029) | 1.74568637 |
| 170 | Abnormality of the fingertips (HP:0001211) | 1.74143731 |
| 171 | Abnormality of iron homeostasis (HP:0011031) | 1.73709859 |
| 172 | Broad face (HP:0000283) | 1.73636891 |
| 173 | Prolonged neonatal jaundice (HP:0006579) | 1.72322074 |
| 174 | Nonimmune hydrops fetalis (HP:0001790) | 1.71980439 |
| 175 | Bulbar palsy (HP:0001283) | 1.70906023 |
| 176 | Athetosis (HP:0002305) | 1.70892214 |
| 177 | J-shaped sella turcica (HP:0002680) | 1.70026277 |
| 178 | Opisthotonus (HP:0002179) | 1.68255666 |
| 179 | Biconcave vertebral bodies (HP:0004586) | 1.68098095 |
| 180 | Progressive neurologic deterioration (HP:0002344) | 1.66405137 |
| 181 | Abnormality of the tricuspid valve (HP:0001702) | 1.65993382 |
| 182 | Meningitis (HP:0001287) | 1.65587517 |
| 183 | Recurrent bacterial skin infections (HP:0005406) | 1.64477126 |
| 184 | Increased IgM level (HP:0003496) | 1.63935612 |
| 185 | Stridor (HP:0010307) | 1.63690747 |
| 186 | Urticaria (HP:0001025) | 1.62178596 |
| 187 | Upper limb amyotrophy (HP:0009129) | 1.60174015 |
| 188 | Distal upper limb amyotrophy (HP:0007149) | 1.60174015 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.68394476 |
| 2 | SMG1 | 3.26808466 |
| 3 | WEE1 | 3.22349610 |
| 4 | EIF2AK1 | 3.08751342 |
| 5 | NME2 | 2.97097161 |
| 6 | CDC7 | 2.90915855 |
| 7 | MAP4K1 | 2.81077904 |
| 8 | PRPF4B | 2.74322889 |
| 9 | TLK1 | 2.58227049 |
| 10 | BCKDK | 2.38539546 |
| 11 | ICK | 2.34330992 |
| 12 | NEK2 | 2.32158728 |
| 13 | STK16 | 2.31240801 |
| 14 | IRAK3 | 2.22774395 |
| 15 | KDR | 2.14159347 |
| 16 | VRK2 | 1.99424980 |
| 17 | EEF2K | 1.97421362 |
| 18 | EIF2AK3 | 1.97295241 |
| 19 | ACVR1B | 1.90581757 |
| 20 | SIK1 | 1.87116117 |
| 21 | TESK2 | 1.84945888 |
| 22 | MAP2K3 | 1.82516368 |
| 23 | MAPKAPK3 | 1.74006104 |
| 24 | ZAP70 | 1.67433386 |
| 25 | MAP3K10 | 1.66486452 |
| 26 | RPS6KB2 | 1.63863649 |
| 27 | FLT3 | 1.62866956 |
| 28 | PKN2 | 1.61377807 |
| 29 | ARAF | 1.59421371 |
| 30 | STK10 | 1.58239604 |
| 31 | TTK | 1.53553756 |
| 32 | ERN1 | 1.50525417 |
| 33 | TSSK6 | 1.46469772 |
| 34 | PASK | 1.45107667 |
| 35 | NEK1 | 1.41738837 |
| 36 | SCYL2 | 1.39016304 |
| 37 | PLK1 | 1.38514535 |
| 38 | VRK1 | 1.37791226 |
| 39 | AURKB | 1.37267521 |
| 40 | RPS6KA4 | 1.35641672 |
| 41 | MAP3K3 | 1.34516412 |
| 42 | ATR | 1.33417871 |
| 43 | TGFBR1 | 1.31198542 |
| 44 | TTN | 1.28806368 |
| 45 | MAP3K11 | 1.27502940 |
| 46 | BRSK2 | 1.25152937 |
| 47 | CDK7 | 1.23995117 |
| 48 | PRKD3 | 1.23626438 |
| 49 | TNK2 | 1.22939178 |
| 50 | CDK4 | 1.22506728 |
| 51 | BTK | 1.22359704 |
| 52 | BRSK1 | 1.17360170 |
| 53 | MAP3K8 | 1.15813563 |
| 54 | DYRK3 | 1.14715929 |
| 55 | KIT | 1.13801610 |
| 56 | GRK6 | 1.13620751 |
| 57 | MKNK1 | 1.13490809 |
| 58 | CCNB1 | 1.11745774 |
| 59 | PLK4 | 1.11613496 |
| 60 | TYK2 | 1.10107442 |
| 61 | SRPK1 | 1.09803503 |
| 62 | CDK8 | 1.06645064 |
| 63 | LRRK2 | 1.05065205 |
| 64 | TXK | 1.05017159 |
| 65 | RIPK4 | 1.04239188 |
| 66 | EPHB1 | 1.03409781 |
| 67 | AURKA | 1.00299246 |
| 68 | TEC | 0.97251744 |
| 69 | TAOK1 | 0.97147395 |
| 70 | MAPK11 | 0.94065106 |
| 71 | PIM2 | 0.92756750 |
| 72 | PIM1 | 0.91899673 |
| 73 | TRIB3 | 0.91709623 |
| 74 | DAPK1 | 0.91640658 |
| 75 | JAK3 | 0.90754991 |
| 76 | BLK | 0.90173137 |
| 77 | STK4 | 0.88143157 |
| 78 | MAP2K6 | 0.87393247 |
| 79 | TESK1 | 0.86588313 |
| 80 | FGFR4 | 0.85036759 |
| 81 | BRAF | 0.81788165 |
| 82 | FES | 0.81381534 |
| 83 | PAK4 | 0.81369160 |
| 84 | RPS6KC1 | 0.81326600 |
| 85 | RPS6KL1 | 0.81326600 |
| 86 | CHEK2 | 0.78829149 |
| 87 | MAP3K6 | 0.73498885 |
| 88 | IRAK4 | 0.73373712 |
| 89 | NEK9 | 0.73065136 |
| 90 | PRKD2 | 0.72895267 |
| 91 | MAPK12 | 0.72812273 |
| 92 | CDK9 | 0.72359798 |
| 93 | CSF1R | 0.70318120 |
| 94 | SYK | 0.68541739 |
| 95 | PDPK1 | 0.66647129 |
| 96 | CHEK1 | 0.64916775 |
| 97 | MAP3K1 | 0.64886491 |
| 98 | SIK3 | 0.64722949 |
| 99 | MAP2K2 | 0.64103494 |
| 100 | RPS6KA2 | 0.63448405 |
| 101 | KSR2 | 0.63265033 |
| 102 | TAOK2 | 0.61180859 |
| 103 | MTOR | 0.58803424 |
| 104 | EPHA2 | 0.58737761 |
| 105 | CSNK2A2 | 0.58517150 |
| 106 | CSNK2A1 | 0.56981768 |
| 107 | RPS6KA6 | 0.56500622 |
| 108 | ATM | 0.54718323 |
| 109 | MARK2 | 0.54292507 |
| 110 | CLK1 | 0.52632286 |
| 111 | MELK | 0.52121545 |
| 112 | HCK | 0.51499412 |
| 113 | IRAK2 | 0.51220697 |
| 114 | MAPK7 | 0.50855861 |
| 115 | RIPK1 | 0.50048217 |
| 116 | CDK2 | 0.49850143 |
| 117 | LYN | 0.49666793 |
| 118 | CDK19 | 0.48926546 |
| 119 | MARK3 | 0.48801058 |
| 120 | TAOK3 | 0.48379983 |
| 121 | RAF1 | 0.48089929 |
| 122 | TBK1 | 0.47866020 |
| 123 | HIPK2 | 0.47617745 |
| 124 | PAK1 | 0.44270835 |
| 125 | NLK | 0.43753251 |
| 126 | LMTK2 | 0.43300988 |
| 127 | MAPKAPK2 | 0.41778407 |
| 128 | MAP3K13 | 0.41710828 |
| 129 | PLK3 | 0.40865244 |
| 130 | PDK1 | 0.40768385 |
| 131 | ILK | 0.40574561 |
| 132 | BMX | 0.39765351 |
| 133 | RPS6KA1 | 0.38585040 |
| 134 | MKNK2 | 0.38505404 |
| 135 | PTK6 | 0.38445602 |
| 136 | LCK | 0.36955728 |
| 137 | IKBKB | 0.36896347 |
| 138 | MAP3K14 | 0.35773961 |
| 139 | MAPKAPK5 | 0.35625070 |
| 140 | RPS6KA5 | 0.34852865 |
| 141 | DYRK1B | 0.34783490 |
| 142 | CDK12 | 0.34278731 |
| 143 | MST1R | 0.33496169 |
| 144 | CDK6 | 0.33314840 |
| 145 | IKBKE | 0.32864132 |
| 146 | AKT2 | 0.31606793 |
| 147 | ITK | 0.29989730 |
| 148 | MAPK4 | 0.29705567 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.24020965 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.55698737 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.90128167 |
| 4 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.77734191 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.60710770 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.36624843 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.23309766 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.21340074 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.19622325 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.12982281 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.09171697 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.06916588 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.06655710 |
| 14 | RNA polymerase_Homo sapiens_hsa03020 | 1.96279644 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.91465855 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.91194039 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86361352 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.83840286 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.83550512 |
| 20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.76301512 |
| 21 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.75294668 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74028775 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.69478941 |
| 24 | Sulfur relay system_Homo sapiens_hsa04122 | 1.66214186 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.61693721 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58919821 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56661330 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56051495 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54843759 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.48454384 |
| 31 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45495520 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42717094 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.41871774 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.34726487 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.34533723 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31256195 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23612083 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23583251 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23504013 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20648474 |
| 41 | RNA degradation_Homo sapiens_hsa03018 | 1.20565340 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.16655954 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15100393 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15082086 |
| 45 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14784777 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13901982 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13570993 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13277391 |
| 49 | Peroxisome_Homo sapiens_hsa04146 | 1.13125048 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11949142 |
| 51 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.08129832 |
| 52 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07381877 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.05912364 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05859894 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 1.04322781 |
| 56 | Bladder cancer_Homo sapiens_hsa05219 | 1.02140821 |
| 57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.00272672 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00100166 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97500119 |
| 60 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96612504 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92935403 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.91995880 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91666978 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.90473826 |
| 65 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.90281078 |
| 66 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90243532 |
| 67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90164287 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89738593 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88099282 |
| 70 | Protein export_Homo sapiens_hsa03060 | 0.86349408 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86339618 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.85705334 |
| 73 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.85162658 |
| 74 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84313508 |
| 75 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84024426 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.83872551 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.83629148 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83104557 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81299098 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.79838151 |
| 81 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.79105412 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77900667 |
| 83 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77671248 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76736042 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76223536 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.75385498 |
| 87 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75325448 |
| 88 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74273449 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73595557 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72695671 |
| 91 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.72682727 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72462771 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72100317 |
| 94 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72064236 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70997716 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.70304289 |
| 97 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70084836 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.69627273 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65452439 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.65419675 |
| 101 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63050674 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62565565 |
| 103 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62505370 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.62394986 |
| 105 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61517975 |
| 106 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61166391 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60437285 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.59924636 |
| 109 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59103469 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57421958 |
| 111 | Hepatitis C_Homo sapiens_hsa05160 | 0.55024102 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54002774 |
| 113 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54000259 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53811726 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53783857 |
| 116 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53702274 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.51163049 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51069046 |
| 119 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49887144 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49786568 |
| 121 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49187103 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49103819 |
| 123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47620062 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.47404170 |
| 125 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46720272 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45811605 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45787371 |
| 128 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45211474 |
| 129 | Lysine degradation_Homo sapiens_hsa00310 | 0.44324604 |
| 130 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43950065 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43228424 |
| 132 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.42883419 |
| 133 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41305418 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40507141 |
| 135 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40041891 |
| 136 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39020935 |
| 137 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34197741 |
| 138 | ABC transporters_Homo sapiens_hsa02010 | 0.34010953 |
| 139 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.33063327 |
| 140 | Legionellosis_Homo sapiens_hsa05134 | 0.32680365 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32020916 |
| 142 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29617869 |
| 143 | Shigellosis_Homo sapiens_hsa05131 | 0.28446714 |
| 144 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27671875 |
| 145 | Measles_Homo sapiens_hsa05162 | 0.26263167 |
| 146 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.24749720 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22122710 |

